QURE
Uniqure Nv
NASDAQ · Biotechnology
$25.65
+1.13 (+4.61%)
Open$25.55
Previous Close$24.52
Day High$28.03
Day Low$25.20
52W High$71.50
52W Low$7.76
Volume—
Avg Volume2.02M
Market Cap1.58B
P/E Ratio—
EPS$-4.39
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
-31.7% upside
Current
$25.65
$25.65
Target
$17.51
$17.51
$11.65
$17.51 avg
$27.07
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 34.34M | 92.13M | 362.13M |
| Net Income | -303,349,284 | -732,531,139 | 45.68M |
| Profit Margin | -883.4% | -839.2% | 12.6% |
| EBITDA | -217,362,741 | -554,050,453 | 50.55M |
| Free Cash Flow | — | — | 25.33M |
| Rev Growth | -62.7% | -62.7% | +18.7% |
| Debt/Equity | 2.39 | 2.39 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |